ACLARION, INC. Payments of Debt Issuance Costs
ACLARION, INC. (ACON) reported Payments of Debt Issuance Costs of $320.56 thousand for the 1-month period ending 2023-11-30, per its 10-Q filed 2024-08-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2024-08-14
- 2023-11-30: Payments of Debt Issuance Costs 1 month $320.56K.
- 2023-09-30: Payments of Debt Issuance Costs 1 month $153.81K.
| Period end | Payments of Debt Issuance Costs 1 month |
|---|---|
| 2023-11-30 | $320.56K 10-Q · filed 2024-08-14 |
| 2023-09-30 | $153.81K 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |